from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1952/vapB14

LFCtreatmentdescriptionclass of inhibitor

0.164

Amikacinug/mL Amikacintranslation

-0.397

Cap5-10ug/mL Capreomycintranslation

-0.218

Rox10-50 ug/mL Roxithromycintranslation

0.714

SM2-5 ug/mL Streptomycintranslation

-0.518

Tet5-10 ug/mL Tetracyclinetranslation

0.503

Rif0.2-5ug/mL Rifampicintranscription

-0.740

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.056

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.614

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.886

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.447

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.059

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.360

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.137

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.669

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.267

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.504

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.067

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.014

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.452

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.596

KCN5-20 ug/mL Potassium cyaniderespiration

-0.719

NaN30.2-2 mM Sodium aziderespiration

1.027

Nigericin50 uM Nigericinrespiration

-0.870

TRC10-150 ug/mL Triclosanrespiration

-0.719

TRZ10-25 ug/mL Thioridazinerespiration

-0.623

Valinomycin0.5-10 uM Valinomycinrespiration

0.784

ZnSO42 mM ZnSO4respiration

-0.065

menadione6-10 ug/mL Menadionerespiration

-0.014

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.380

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.482

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.738

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

2.129

NRP_1Non-replicating persistence stage 1dosRassociated

0.711

Amp0.2mg/mL AmpicillincellWall

0.048

Cephalexin20-100 ug/mL CephalexincellWall

0.153

Cerulenin0.32-5 ug/mL CerulenincellWall

0.285

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.193

EMB10-20 ug/mL EthambutolcellWall

-0.099

Eta12-40 ug/mL EthionamidecellWall

-0.595

INH0.2-0.4 ug/mL IsoniazidcellWall

0.180

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.036

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.144

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.165

BZA0.12 mg/mL BenzamidearomaticAmides

0.122

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.302

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.231

H2O24 mM hydrogen peroxideDNAdamaging

-0.151

Levo10 ug/mL LevofloxacinDNAdamaging

0.394

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.577

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.532

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.510

UVUV-irradiationDNAdamaging

-0.092

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.001

Antimycin12.5-50 ug/mL Antimycin A?

0.269

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.593

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.069

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.152

PA8240.2-2 ug/mL PA-824?

-0.637

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.266

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.004

Verapamil50 uM Verapamil?

0.289

mercaptoethanol2 mM 2-Mercaptoethanol?

0.210

methoxatin10-20 ug/mL Methoxatin?